origin
hepat
c
viru
hcv
infect
human
remain
unknown
relat
anim
viru
homolog
identifi
recent
flavivirida
rna
genom
isol
domest
dog
respiratori
ill
found
viru
close
relat
hcv
flavivirida
agent
known
canin
hepaciviru
chv
discoveri
chv
may
shed
light
origin
hcv
may
also
serv
new
model
system
studi
deadli
human
viru
chvlike
virus
also
known
nonprim
hepacivirus
nphv
also
recent
identifi
hors
hcv
belong
genu
hepaciviru
one
four
genera
famili
flavivirida
hcv
infect
million
peopl
worldwid
http
one
lead
caus
liver
cirrhosi
failur
although
discoveri
close
homolog
chv
hcv
intrigu
barrier
prevent
viral
transmiss
across
speci
crossspeci
transmiss
chv
human
would
like
requir
evas
human
cellular
innat
immun
respons
lead
type
interferon
product
rna
activ
retino
acid
induc
genei
rigi
tolllik
receptor
tlr
number
hostencod
restrict
factor
protect
human
cell
viral
infect
well
character
model
retrovirus
human
genom
evolv
constel
antivir
gene
potenti
target
retrovirus
gene
part
innat
immun
system
retroviru
literatur
often
call
restrict
factor
wellcharacter
restrict
factor
protein
tetherin
inhibit
human
immunodefici
viru
hiv
propag
variou
step
replic
cycl
evolut
gene
encod
restrict
factor
affect
adapt
hiv
human
current
pandem
adapt
primat
lentivirus
modern
host
case
hcv
signal
pathway
lead
type
interferon
product
first
line
defenc
employ
host
combat
virus
repres
barrier
invad
virus
must
overcom
order
establish
infect
major
strategi
employ
hcv
subvert
host
innat
immun
respons
disrupt
rigi
tlrsignal
pathway
hcv
proteas
cleavag
adaptor
protein
mav
trif
mav
multipl
primat
resist
inhibit
hcv
proteas
resist
map
singl
chang
within
proteas
cleavag
site
mav
protect
mav
get
cleav
hcv
proteas
chang
like
driven
ancient
hepacivirus
provid
insight
hepacivir
infect
cours
primat
evolut
propag
chv
nphv
human
would
like
overcom
human
innat
host
defenc
mediat
type
interferon
hypothes
chv
proteas
could
specif
process
human
adaptor
protein
mav
trif
test
hypothesi
coexpress
chv
proteas
specif
mav
trif
cleavag
site
known
process
vivo
hcv
proteas
use
approach
demonstr
chv
proteas
cleav
human
mav
trif
catalyt
activ
chv
proteas
assay
use
bacteriophag
genet
screen
previous
demonstr
bacteriophag
genet
screen
employ
use
character
sitespecif
proteas
includ
hcv
hiv
respiratori
syndrom
sar
coronaviru
proteas
genet
screen
base
bacteriophag
lambda
cicro
regulatori
circuit
viral
repressor
ci
specif
cleav
initi
switch
lysogeni
lytic
infect
genet
screen
simpl
altern
approach
purif
character
express
proteas
vitro
classic
methodolog
specif
cleavag
site
engin
lambda
ci
repressor
assay
studi
depict
fig
site
includ
specif
mav
trif
cleavag
site
known
process
vivo
hcv
proteas
well
chv
hcv
viral
polyprotein
cleavag
site
mutat
version
trif
cleavag
site
also
includ
control
target
specif
mav
trif
cleavag
site
test
coexpress
chv
hcv
proteas
construct
proteas
construct
contain
residu
fuse
frame
via
short
linker
amino
terminu
proteas
domain
residu
fig
chv
proteas
construct
chemic
synthes
follow
nucleotid
sequenc
report
kapoor
et
al
upon
infect
e
coli
cell
coexpress
lambda
ci
repressor
either
mav
trif
cleavag
site
chv
construct
lambda
phage
replic
effici
cell
express
chv
proteas
variant
includ
substitut
catalyt
residu
fig
equival
result
obtain
four
hcv
genotyp
assay
three
assay
hcv
proteas
isol
three
hcvinfect
patient
fourth
hcv
proteas
amplifi
hcv
subgenom
replicon
investig
influenc
protein
catalyt
effici
chv
proteas
chv
residu
replac
residu
fig
hcv
residu
critic
activ
hcv
proteas
similar
hcv
proteas
mutat
version
chv
reduc
catalyt
effici
chv
proteas
indic
chv
peptid
essenti
effici
process
mav
trif
cleavag
site
fig
nevertheless
effect
mutat
residu
chv
proteas
activ
less
drastic
observ
hcv
proteas
fig
see
test
target
specif
mav
trif
cleavag
site
analyz
control
mutant
trif
target
site
mutant
trif
cleavag
site
construct
c
residu
posit
substitut
residu
fig
shown
fig
mutant
trif
cleavag
site
prevent
phage
replic
indic
trif
process
specif
mediat
chv
proteas
western
blot
analysi
also
demonstr
fig
express
chv
proteas
result
nearli
complet
cleavag
lambda
ci
repressor
either
mav
fig
trif
cleavag
site
fig
express
proteas
includ
substitut
catalyt
residu
fig
complet
abolish
cleavag
lambda
ci
repressor
either
mav
trif
cleavag
site
express
proteas
mutat
version
partial
abolish
wildtyp
mav
trif
repressor
cleavag
fig
specif
mutat
less
impact
activ
chv
proteas
activ
hcv
proteas
fig
expect
control
mutant
trif
target
site
fig
cleav
wildtyp
proteas
overal
result
demonstr
chv
proteas
abl
specif
cleav
human
adaptor
protein
mav
trif
next
investig
whether
chv
hcv
proteas
could
specif
process
heterolog
viral
polyprotein
cleavag
site
chv
hcv
cleavag
site
engin
fig
test
proteas
interestingli
chv
hcv
proteas
process
heterolog
viral
cleavag
site
compar
effici
fig
suggest
chv
hcv
proteas
may
share
evolutionari
linag
final
two
macrocycl
hcv
proteas
inhibitor
danoprevir
assay
test
abil
inhibit
chv
proteas
macrocycl
inhibitor
chosen
higher
potenc
differ
hcv
genotyp
compar
linear
inhibitor
inhibitori
capabl
two
macrocycl
inhibitor
assess
mav
trif
cleavag
site
expect
danoprevir
inhibit
hcv
proteas
fig
test
either
cleavag
site
contrast
signific
inhibit
observ
either
two
inhibitor
assay
chv
proteas
note
posit
associ
resist
macrocycl
hcv
proteas
inhibitor
hcv
residu
mutat
chv
proteas
sequenc
fig
specif
inhibit
test
includ
hcv
proteas
mutant
carri
proteas
inhibitor
resist
substitut
substitut
reduc
inhibitori
capac
two
test
proteas
inhibitor
fig
recent
studi
identifi
virus
domest
dog
hors
genet
close
relat
hcv
find
suggest
hcv
could
introduc
human
popul
contact
dog
andor
hors
nevertheless
adapt
chv
nphv
human
cell
would
like
requir
virus
evad
human
cellular
innat
immun
respons
respond
viral
pathogen
rna
activ
rigi
subsequ
signal
via
interferon
regulatori
factor
irf
respons
hcv
infect
regul
hepat
immun
defenc
trigger
cellular
rigi
human
liver
cell
hcv
interfer
signal
cleavag
crucial
adaptor
protein
mav
likewis
signal
ablat
cleavag
trif
hcv
proteas
studi
test
abil
chv
proteas
specif
cleav
human
adaptor
protein
mav
trif
found
chv
proteas
could
process
compar
effici
specif
mav
trif
cleavag
site
known
process
vivo
hcv
proteas
find
extend
previou
report
confirm
possibl
evolutionari
relationship
chv
hcv
result
studi
indic
chv
disrupt
human
innat
antivir
defens
signal
pathway
addit
studi
also
show
similar
hcv
proteas
chv
proteas
effici
regul
viral
protein
suggest
mechan
action
substrat
specif
similar
two
proteas
chv
polypeptid
improv
cleavag
mav
trifspecif
cleavag
site
howev
chv
proteas
suscept
macrocycl
inhibitor
hcv
proteas
import
hcv
differ
efficaci
proteas
inhibitor
report
recent
hcv
proteas
inhibitor
clinic
develop
identifi
use
hcv
replicon
system
genotyp
licens
treatment
genotyp
infect
vitro
studi
perform
hcv
chimera
shown
genotyp
similar
sensit
wherea
genotyp
compar
resist
macrocycl
hcv
proteas
inhibitor
chv
proteas
amino
acid
chang
posit
associ
resist
macrocycl
hcv
proteas
inhibitor
would
explain
proteas
resist
macrocycl
hcv
proteas
inhibitor
gb
viru
b
gbvb
anoth
hepaciviru
discoveri
chvnhv
viru
phylogenet
close
relat
hcv
gbvb
infect
human
chimpanze
caus
acut
hepat
experiment
infect
tamarin
type
new
world
monkey
although
import
differ
outcom
hcv
gbvb
infect
gbvb
rare
caus
persist
infect
gbvb
evolv
strategi
similar
employ
hcv
result
disrupt
rigi
signal
inde
gbvb
proteolyt
cleav
human
mav
distantli
relat
hepaciviru
gbvc
infect
human
chimpanze
gbva
also
abl
antagon
mav
contrast
proteas
distantli
relat
pestiviru
bovin
viral
diarrhea
viru
flaviviru
yellow
fever
viru
antagon
mav
overal
data
suggest
abil
proteas
antagon
mav
phylogenet
discret
characterist
exclus
hcv
three
gbv
virus
base
observ
chv
abl
cleav
canin
mav
trif
protein
canin
ortholog
human
mav
trif
differ
sequenc
cleavag
site
process
hcv
proteas
therefor
test
studi
inspect
canin
mav
trif
protein
reveal
presenc
appar
substrat
specif
hcv
proteas
although
chv
initi
found
dog
subsequ
effort
find
similar
virus
canid
remain
larg
unsuccess
recent
evid
chvlike
viru
infect
confirm
detect
divers
viral
genom
term
nphv
hors
hors
support
replic
sever
flavivirus
includ
vectorborn
west
nile
japanes
enceph
dengu
st
loui
enceph
virus
flavivirus
transmit
among
sever
mammalian
speci
includ
human
nphv
strain
detect
hors
genet
distinct
chv
howev
one
variant
almost
ident
chv
suggest
chvnphv
virus
may
abl
jump
speci
first
studi
knowledg
demonstr
least
part
identifi
sequenc
chvnphv
rna
genom
biolog
activ
initi
attempt
cultur
chv
success
singl
strain
hcv
genotyp
strain
japanes
patient
found
grow
robustli
cultur
human
hepatoma
cell
line
howev
viabl
recombin
gene
element
specif
hcv
genotyp
develop
given
difficulti
cultur
hcv
result
suggest
may
possibl
gener
hcvchv
chimera
cultiv
studi
limit
worth
note
first
studi
test
function
small
chv
genom
region
chvnphv
genom
region
previous
describ
analyz
guarante
viabil
futur
hcvchv
chimera
second
vitro
approach
use
measur
abil
proteas
cleav
human
adaptor
mav
trif
partial
mimic
occur
vivo
third
determin
whether
chv
proteas
effici
cleavag
mav
trif
protein
equival
hors
canin
primari
host
nevertheless
similar
observ
hcv
chv
proteas
capabl
process
mav
trif
well
hcvchv
cleavag
site
strongli
support
hypothesi
chv
might
abl
disrupt
human
innat
antivir
defens
signal
pathway
work
includ
evalu
abil
chv
proteas
process
human
canin
adaptor
protein
mav
trif
human
canin
hepatoma
cell
line
well
construct
hcvchv
chimera
explor
hypothesi
perform
function
studi
relat
hepaciviru
pathogenesi
treatment
insert
mav
hcv
cleavag
site
fig
lambda
ci
repressor
describ
elsewher
studi
trif
chv
cleavag
site
fig
insert
lambda
ci
repressor
briefli
nucleotid
sequenc
trif
chv
cleavag
site
fig
chemic
synthes
integr
dna
technolog
construct
includ
two
restrict
site
nsii
hindiii
end
present
lambda
ci
repressor
digest
nsii
hindiii
construct
ligat
previous
digest
nsii
hindiii
gener
pcitrifcro
plasmid
sequenc
analysi
plasmid
confirm
accuraci
synthet
construct
e
coli
cell
contain
plasmid
pcimavscro
pcitrifcro
transform
plasmid
express
correspond
proteas
transform
cell
grown
overnight
presenc
maltos
tetracyclin
ampicillin
harvest
centrifug
resuspend
optic
densiti
nm
mm
induc
express
proteas
cell
incub
luriabertani
lb
medium
contain
tetracyclin
ampicillin
maltos
mm
mm
iptg
h
cell
cultur
infect
plaqueform
unit
pfu
phage
h
titer
result
phage
determin
coplat
cultur
e
coli
blue
cell
adjust
optic
densiti
nm
mm
lb
plate
use
ml
top
agar
contain
tetracyclineml
maltos
mm
iptg
incub
h
result
phage
plaqu
count
order
score
growth
western
blot
perform
previous
describ
briefli
e
coli
cell
contain
plasmid
pcimavscro
pcitrifcro
transform
plasmid
express
correspond
proteas
transform
cell
grown
overnight
presenc
maltos
tetracyclin
ampicillin
harvest
centrifug
resuspend
optic
densiti
nm
mm
induc
express
proteas
cell
incub
ml
lb
medium
contain
tetracyclin
ampicillin
maltos
mm
mm
iptg
h
od
cultur
h
presenc
iptg
measur
assur
equival
amount
total
cell
protein
blot
signific
differ
observ
od
differ
cultur
compar
suggest
express
proteas
affect
growth
bacteria
cultur
lyse
sodium
dodecyl
sulfat
sd
polyacrylamid
gel
electrophoresi
sampl
buffer
resolv
gradient
sd
polyacrylamid
gel
invitrogen
transfer
nitrocellulos
membran
block
phosphatebuff
tween
nonfat
dri
milk
immunochem
detect
lambda
repressor
membran
subsequ
incub
rabbit
serum
contain
polyclon
antici
antibodi
antici
sera
invitrogen
bound
antibodi
visual
peroxidaselink
antirabbit
antybodi
hrplink
igg
cell
signal
technolog
supersign
west
pico
chemiluminesc
substrat
thermo
scientif
nucleotid
sequenc
chv
proteas
fig
chemic
synthes
integr
dna
technolog
follow
nucleotid
sequenc
report
kapoor
et
al
construct
includ
two
restrict
site
ecori
xhoi
end
digest
ecori
xhoi
construct
clone
pbluescript
agil
technolog
gener
proteas
fusion
protein
sequenc
analysi
plasmid
confirm
accuraci
synthet
construct
control
mutant
construct
red
residu
fig
gener
sitedirect
mutagenesi
use
quikchang
kit
agil
technolog
follow
manufactur
instruct
three
hcv
proteas
use
studi
obtain
hcv
genom
rna
extract
plasma
three
differ
hcvinfect
patient
nucleotid
sequenc
amplif
procedur
proteas
publish
previous
fourth
hcv
proteas
employ
studi
amplifi
hcv
subgenom
replicon
macrocycl
proteas
inhibitor
kindli
provid
merck
sharp
dohm
donoprevir
purchas
selleck
chemic
houston
tx
usa
